Moderate ethanol ingestion and cardiovascular protection: From epidemiologic associations to cellular mechanisms

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 1, 2012, Pages 93-104

  Krenz, Maike ^a,b   Korthuis, Ronald J ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Alcohol; Coronary disease; Epidemiology; Ethanol preconditioning; Inflammation; Ischemia reperfusion; Myocardial infarction; Signaling; Stroke

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALCOHOL; ALDEHYDE DEHYDROGENASE; APOLIPOPROTEIN A1; BRADYKININ; C REACTIVE PROTEIN; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROTECTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRINKING BEHAVIOR; FISH; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC PRECONDITIONING; MEDITERRANEAN DIET; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RED WINE; REVIEW; RISK FACTOR; RISK REDUCTION; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ALCOHOL DRINKING; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR DISEASES; ETHANOL; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCYTES, CARDIAC; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STROKE;

ANIMALIA;

EID: 84155188950     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.10.011     Document Type: Review

References (214)

1. Brust J.C. Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health 2010, 7:1540-1557.
2. Chen G., Luo J. Anthocyanins: are they beneficial in treating ethanol neurotoxicity?. Neurotox Res 2010, 17:91-101.
3. Cohen J.I., Nagy L.E. Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells. J Dig Dis 2011, 12:3-9.
4. Miranda-Mendez A., Lugo-Baruqui A., Armendariz-Borunda J. Molecular basis and current treatment for alcoholic liver disease. Int J Environ Res Public Health 2010, 7:1872-1888.
5. Mukamal K. Alcohol intake and noncoronary cardiovascular diseases. Ann Epidemiol 2007, 17:S8-S12.
6. Patra J., Taylor B., Irving H., Roerecke M., Baliunas D., Mohapatra S., et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 2010, 10:258.
7. Reidy J., McHugh E., Stassen L.F. A review of the relationship between alcohol and oral cancer. Surgeon 2011, 9:278-283.
8. Seitz H.K., Cho C.H. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol 2009, 472:217-241.
9. Seitz HK, Becker P. Alcohol metabolism and cancer risk. Alcohol Res Health 2007; 30:38-41, 4-7.
10. Xu M., Bower K.A., Chen G., Shi X., Dong Z., Ke Z., et al. Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin. Alcohol Clin Exp Res 2010, 34:751-760.
11. Wang Y., Seitz H.K., Wang X.D. Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcohol Clin Exp Res 2010, 34:567-573.
12. Klatsky A.L., Friedman G.D., Siegelaub A.B. Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med 1974, 81(3):294-301.
13. Brien S.E., Ronksley P.E., Turner B.J., Mukamal K.J., Ghali W.A. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011, 342:d636.
14. Camargo C.A., Hennekens C.H., Gaziano J.M., Glynn R.J., Manson J.E., Stampfer M.J. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med 1997, 157(1):79-85. 13.
15. Corrao G., Rubbiati L., Bagnardi V., Zambon A., Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000, 95(10):1505-1523.
16. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation 2010, 121:1951-1959.
17. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 2010, 55:1339-1347.
18. Di Castelnuovo A., Costanzo S., Bagnardi V., Donati M.B., Iacoviello L., de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 2006, 166:2437-2445.
19. Di Castelnuovo A., Costanzo S., di Giuseppe R., de Gaetano G., Iacoviello L. Alcohol consumption and cardiovascular risk: mechanisms of action and epidemiologic perspectives. Future Cardiol 2009, 5:467-477.
20. Di Castelnuovo A., Costanzo S., Donati M.B., Iacoviello L., de Gaetano G. Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms. Intern Emerg Med 2010, 5:291-297.
21. Doll R., Peto R., Hall E., Wheatley K., Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ 1994, 309:911-918.
22. Dufour M.C., Caces M.F., Whitmore C.C., Hanna E.Z. Alcohol consumption and death from acute myocardial infarction in a national longitudinal cohort. Alcohol Clin Exp Res 1996, 20:97A.
23. Femia R., Natali A., L'Abbate A., Ferrannini E. Coronary atherosclerosis and alcohol consumption: angiographic and mortality data. Arterioscler Thromb Vasc Biol 2006, 26:1607-1612.
24. Freiberg M.S., Samet J.H. Alcohol and coronary heart disease: the answer awaits a randomized controlled trial. Circulation 2005, 112:1379-1381.
25. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannucci E.L., Manson J.E., Kawachi I., et al. Alcohol consumption and mortality among women. N Engl J Med 1995, 332:1245-1250.
26. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993, 329:1829-1834.
27. Gibson B.T., Ong J.H., Starnes J.W., Farrar R.P. Effects of chronic moderate and heavy ethanol consumption on myocardial recovery from ischemia. Alcohol Clin Exp Res 1998, 22(9):2086-2092.
28. Ginter E., Simko V. Ethanol and cardiovascular diseases: epidemiological, biochemical and clinical aspects. Bratisl Lek Listy 2008, 109:590-594.
29. Gronbaek M., Becker U., Johansen D., Gottschau A., Schnohr P., Hein H.O., et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Ann Intern Med 2000, 133(6):411-419. 19.
30. Jackson R., Broad J., Connor J., Wells S. Alcohol and ischaemic heart disease: probably no free lunch. Lancet 2005, 366:1911-1912.
31. Kabagambe E.K., Baylin A., Ruiz-Narvaez E., Rimm E.B., Campos H. Alcohol intake, drinking patterns, and risk of nonfatal acute myocardial infarction in Costa Rica. Am J Clin Nutr 2005, 82:1336-1345.
32. Klatsky A.L. Alcohol and cardiovascular diseases. Expert Rev Cardiovasc Ther 2009, 7:499-506.
33. Klatsky A.L. Alcohol and cardiovascular health. Integr Comp Biol 2004, 44:324-328.
34. Klatsky A.L. Alcohol and cardiovascular mortality: common sense and scientific truth. J Am Coll Cardiol 2010, 55:1336-1338.
35. Klatsky A.L., Armstrong M.A., Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990, 66:1237-1242.
36. Mukamal K.J., Chen C.M., Rao S.R., Breslow R.A. Alcohol consumption and cardiovascular mortality among U.S. adults, 1987 to 2002. J Am Coll Cardiol 2010, 55:1328-1335.
37. Mukamal K.J., Chiuve S.E., Rimm E.B. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Arch Intern Med 2006, 166:2145-2150.
38. Mukamal K.J., Conigrave K.M., Mittleman M.A., Camargo C.A., Stampfer M.J., Willett W.C., et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 2003, 348:109-118.
39. Mukamal K.J., Jensen M.K., Gronbaek M., Stampfer M.J., Manson J.E., Pischon T., et al. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 2005, 112:1406-1413.
40. Nakamura Y., Kawi C., Kinoshito M., Moss A.J. Moderate alcohol intake and outcome after an acute coronary event. Circulation 1995, 92:I-708.
41. Elkind M.S., Sciacca R., Boden-Albala B., Rundek T., Paik M.C., Sacco R.L. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006, 37:13-19.
42. O'Keefe J.H., Bybee K.A., Lavie C.J. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007, 50:1009-1014.
43. Rajpathak S.N., Freiberg M.S., Wang C., Wylie-Rosett J., Wildman R.P., Rohan T.E., et al. Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational Study. Eur J Nutr 2010, 49:211-218.
44. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339(8808):1523-1526.
45. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991, 338:464-468.
46. Rimm E.B., Williams P., Fosher K., Criqui M., Stampfer M.J. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999, 319:1523-1528.
47. Ronksley P.E., Brien S.E., Turner B.J., Mukamal K.J., Ghali W.A. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011, 342:d671.
48. Ruidavets J.B., Ducimetiere P., Evans A., Montaye M., Haas B., Bingham A., et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). BMJ 2010, 341:c6077.
49. Saremi A., Arora R. The cardiovascular implications of alcohol and red wine. Am J Ther 2008, 15:265-277.
50. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E., Hennekens C.H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988, 319:267-273.
51. Tanasescu M., Hu F.B., Willett W.C., Stampfer M.J., Rimm E.B. Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol 2001, 38:1836-1842.
52. Mukherjee S., Lekli I., Narasimman G., Bertelli A.A.A., Das D.K. Expression of longevity proteins in both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol. Free Radic Biol Med 2009, 46:573-578.
53. Wu J.M., Hsieh T.-c. Resveratrol: a cardioprotective substance. N Y Acad Sci 2011, 1215:16-21.
54. Rodrigo R., Miranda A., Vergara L. Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta 2011, 12:410-424.
55. Shigematsu S., Ishida S., Hara M., Takahashi N., Yoshimatsu H., Sakata T., et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 2003, 34:810-817.
56. Sun A.Y., Wang Q., Simonyi A., Sun G.Y. Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 2010, 41:375-383.
57. Wang Q., Sun A.Y., Simonyi A., Miller D.K., Smith R.E., Luchtefeld R.G., et al. Oral administration of grape polyphenol extract ameliorates cerebral ischemia/reperfusion-induced neuronal damage and behavioral deficits in gerbils: comparison of pre- and post-ischemic administration. J Nutr Biochem 2009, 20:369-377.
58. Shinmura K. Cardiovascular protection afforded by caloric restriction: essential role of nitric oxide synthase. Geriatr Gerontol Int 2011, 11:143-156.
59. Collins M.A., Neafsey E.J., Mukamal K.J., Gray M.O., Parks D.A., Das D.K., et al. Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res 2009, 33:206-219.
60. Eagon P.K. Alcoholic liver injury: influence of gender and hormones. World J Gastroenterol 2010, 16:1377-1384.
61. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
62. Beulens J.W., Rimm E.B., Ascherio A., Spiegelman D., Hendriks H.F., Mukamal K.J. Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med 2007, 146:10-19.
63. Gigleux I., Gagnon J., St-Pierre A., Cantin B., Dagenais G.R., Meyer F., et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr 2006, 136:3027-3032.
64. Klatsky A.L. Alcohol and stroke: an epidemiological labyrinth. Stroke 2005, 36:1835-1836.
65. Koppes L.L., Dekker J.M., Hendriks H.F., Bouter L.M., Heine R.J. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005, 28:719-725.
66. Mukamal K.J., Ding E.L., Djousse L. Alcohol consumption, physical activity, and chronic disease risk factors: a population-based cross-sectional survey. BMC Public Health 2006, 6:118.
67. Mukamal K.J., Kuller L.H., Fitzpatrick A.L., Longstreth W.T., Mittleman M.A., Siscovick D.S. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA 2003, 289:1405-1413.
68. O'Keefe J.H., Carter M.D., Lavie C.J. Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clin Proc 2009, 84:741-757.
69. Schminke U., Luedemann J., Berger K., Alte D., Mitusch R., Wood W.G., et al. Association between alcohol consumption and subclinical carotid atherosclerosis: the Study of Health in Pomerania. Stroke 2005, 36:1746-1752.
70. Greenfield J.R., Samaras K., Hayward C.S., Chisholm D.J., Campbell L.V. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: modification by insulin resistance. J Clin Endocrinol Metab 2005, 90:661-672.
71. Gorelick P.B., Rodin M.B., Langenberg P., Hier D.B., Costigan J. Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois. Neurology 1989, 39:339-343.
72. Turner B.C., Jenkins E., Kerr D., Sherwin R.S., Cavan D.A. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 2001, 24:1888-1893.
73. van de Wiel A., de Lange D.W. Cardiovascular risk is more related to drinking pattern than to the type of alcoholic drinks. Neth J Med 2008, 66:467-473.
74. de Leiris J., Besse S., Boucher F. Diet and heart health: moderate wine drinking strengthens the cardioprotective effects of fish consumption. Curr Pharm Biotechnol 2010, 11:911-921.
75. Djousse L., Gaziano J.M. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep 2008, 10:117-120.
76. Djousse L., Gaziano J.M. Alcohol consumption and risk of heart failure in the Physicians' Health Study I. Circulation 2007, 115:34-39.
77. Goldstein L.B., Bushnell C.D., Adams R.J., Appel L.J., Braun L.T., Chaturvedi S., et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:517-584.
78. Ma Z.W., Feng X.B., Zheng S.G., Bie P., Wang S.G., Li K., et al. Ethanol preconditioning reduces hepatic I/R injury by inhibiting the complement system activation. J Surg Res 2011, 166:314-323.
79. Mukamal K.J., Tolstrup J.S., Friberg J., Jensen G., Gronbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation 2005, 112:1736-1742.
80. Kalogeris T, Baines C, Krenz M, Korthuis. Invited Review: Cell biology of ischemia/reperfusion injury: Prevention of Ischemic Injury by Preconditioning and Stem Cell Therapy. Int Rev Cell Mol Biol under review.
81. Liu Y, Kalogeris T, Wang M, Zuidema M, Wang Q, Dai H, Davis MH, Hill MA, Korthuis RJ. Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia/reperfusion-induced mitochondrial dysfunction in rat small intestine. Am J Physiol (Electronic publication ahead of print, September 15, 2011). doi:. doi:10.1152/ajpgi.00413.2010.
82. Lucas D.L., Brown R.A., Wassef M., Giles T.D. Alcohol and the cardiovascular system: research challenges and opportunities. J Am Coll Cardiol 2005, 45:1916-1924.
83. Suter L.G., Murabito J.M., Felson D.T., Fraenkel L. Smoking, alcohol consumption, and Raynaud's phenomenon in middle age. Am J Med 2007, 120:264-271.
84. Janszky I., Ericson M., Blom M., Georgiades A., Magnusson J.O., Alinagizadeh H., et al. Wine drinking is associated with increased heart rate variability in women with coronary heart disease. Heart 2005, 91:314-318.
85. Albert M.A., Glynn R.J., Ridker P.M. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003, 107:443-447.
86. Sierksma A., Patel H., Ouchi N., Kihara S., Funahashi T., Heine R.J., et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 2004, 27:184-189.
87. Sierksma A., van der Gaag M.S., Kluft C., Hendriks H.F. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 2002, 56:1130-1136.
88. Zairis M.N., Ambrose J.A., Lyras A.G., Thoma M.A., Psarogianni P.K., Psaltiras P.G., et al. C Reactive protein, moderate alcohol consumption, and long term prognosis after successful coronary stenting: four year results from the GENERATION study. Heart 2004, 90:419-424.
89. Jackson G. Gender differences in cardiovascular disease prevention. Menopause Int 2008, 14:13-17.
90. Naimi T.S., Brown D.W., Brewer R.D., Giles W.H., Mensah G., Serdula M.K., et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med 2005, 28:369-373.
91. Chiuve S.E., Rexrode K.M., Spiegelman D., Logroscino G., Manson J.E., Rimm E.B. Primary prevention of stroke by healthy lifestyle. Circulation 2008, 118:947-954.
92. Ellison R.C. Continuing reluctance to accept emerging scientific data on alcohol and health. AIM Dig 2002, 11:6-7.
93. Kloner R.A., Rezkalla S.H. To drink or not to drink? That is the question. Circulation 2007, 116(11):1306-1317.
94. Lee S.J., Sudore R.L., Williams B.A., Lindquist K., Chen H.L., Covinsky K.E. Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc 2009, 57:955-962.
95. Walzem R.L. Wine and health: state of proofs and research needs. Inflammopharmacology 2008, 16:265-271.
96. Brinton E.A. Effects of ethanol intake on lipoproteins and atherosclerosis. Curr Opin Lipidol 2010, 21:346-351.
97. Demrow H.S., Slane P.R., Folts J.D. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995, 91(4):1182-1188.
98. Fumeron F., Betoulle D., Luc G., Behague I., Ricard S., Poirier O., et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995, 96:1664-1671.
99. Keller J.W., Folts J.D. Relative effects of cigarette smoke and ethanol on acute platelet thrombus formation in stenosed canine coronary arteries. Cardiovasc Res 1988, 22(1):73-78.
100. McKenzie C.R., Abendschein D.R., Eisenberg P.R. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa. Arterioscler Thromb Vasc Biol 1996, 16:1285-1291.
101. Miceli M., Alberti L., Bennardini F., Di Simplicio P., Seghieri G., Rao G.H., et al. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. Life Sci 2003, 73:1557-1566.
102. Mukamal K.J., Massaro J.M., Ault K.A., Mittleman M.A., Sutherland P.A., Lipinska I., et al. Alcohol consumption and platelet activation and aggregation among women and men: the Framingham Offspring Study. Alcohol Clin Exp Res 2005, 29:1906-1912.
103. Pikaar N.A., Wedel M., van der Beek E.J., van Dokkum W., Kempen H.J., Kluft C., et al. Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism 1987, 36:538-543.
104. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992, 55:1012-1017.
105. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994, 272:929-933.
106. Tozzi Ciancarelli M.G., Di Massimo C., De Amicis D., Ciancarelli I., Carolei A. Moderate consumption of red wine and human platelet responsiveness. Thromb Res 2011, 128:124-129.
107. Trichopoulou A., Bamia C., Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ 2009, 338:b2337.
108. Veenstra J., Ockhuizen T., van de Pol H., Wedel M., Schaafsma G. Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. Alcohol Alcohol 1990, 25:371-377.
109. Vliegenthart R., Oei H.H., van den Elzen A.P., van Rooij F.J., Hofman A., Oudkerk M., et al. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 2004, 164:2355-2360.
110. Volcik K.A., Ballantyne C.M., Fuchs F.D., Sharrett A.R., Boerwinkle E. Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol 2008, 18:101-107.
111. Davies M.J., Baer D.J., Judd J.T., Brown E.D., Campbell W.S., Taylor P.R. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA 2002, 287(19):2559-2562.
112. Marfella R., Cacciapuoti F., Siniscalchi M., Sasso F.C., Marchese F., Cinone F., et al. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med 2006, 23(9):974-981.
113. Joosten M.M., Beulens J.W., Kersten S., Hendriks H.F. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia 2008, 51:1375-1381.
114. Conigrave K.M., Rimm E.B. Alcohol for the prevention of type 2 diabetes mellitus?. Treat Endocrinol 2003, 2(3):145-152.
115. Gillman M.W., Cook N.R., Evans D.A., Rosner B., Hennekens C.H. Relationship of alcohol intake with blood pressure in young adults. Hypertension 1995, 25(5):1106-1110.
116. Kiviniemi T.O., Saraste A., Toikka J.O., Saraste M., Raitakari O.T., Parkka J.P., et al. A moderate dose of red wine, but not de-alcoholized red wine increases coronary flow reserve. Atherosclerosis 2007, 195(2):e176-e181.
117. Kleinhenz D.J., Sutliff R.L., Polikandriotis J.A., Walp E.R., Dikalov S.I., Guidot D.M., et al. Chronic ethanol ingestion increases aortic endothelial nitric oxide synthase expression and nitric oxide production in the rat. Alcohol Clin Exp Res 2008, 32(1):148-154.
118. Abou-Agag L.H., Khoo N.K., Binsack R., White C.R., Darley-Usmar V., Grenett H.E., et al. Evidence of cardiovascular protection by moderate alcohol: role of nitric oxide. Free Radic Biol Med 2005, 39(4):540-548. 15.
119. Gazzieri D., Trevisani M., Tarantini F., Bechi P., Masotti G., Gensini G.F., et al. Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide. Cardiovasc Res 2006, 70:589-599.
120. Booyse F.M., Pan W., Grenett H.E., Parks D.A., Darley-Usmar V.M., Bradley K.M., et al. Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann Epidemiol 2007, 17:S24-S31.
121. Zenebe W., Pechanova O., Andriantsitohaina R. Red wine polyphenols induce vasorelaxation by increased nitric oxide bioactivity. Physiol Res 2003, 52(4):425-432.
122. Spaak J., Merlocco A.C., Soleas G.J., Tomlinson G., Morris B.L., Picton P., et al. Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter. Am J Physiol Heart Circ Physiol 2008, 294:H605-H612.
123. Krenz M., Baines C.P., Heusch G., Downey J.M., Cohen M.V. Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning. J Mol Cell Cardiol 2001, 33(11):2015-2022.
124. Krenz M., Baines C.P., Yang X.M., Heusch G., Cohen M.V., Downey J.M. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol 2001, 37(2):601-607.
125. Niccoli G., Altamura L., Fabretti A., Lanza G.A., Biasucci L.M., Rebuzzi A.G., et al. Ethanol abolishes ischemic preconditioning in humans. J Am Coll Cardiol 2008, 51(3):271-275.
126. Krenz M., Yang X.M., Qin Q., Downey J.M., Cohen M.V. Dose-response relationships of the protective and antiprotective effects of acute ethanol exposure in isolated rabbit hearts. Heart Dis 2002, 4(5):276-281.
127. McDonough K.H. Chronic alcohol consumption causes accelerated myocardial preconditioning to ischemia-reperfusion injury. Alcohol Clin Exp Res 1997, 21:869-873.
128. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
129. Yellon D.M., Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003, 83(4):1113-1151.
130. Yang X., Cohen M.V., Downey J.M. Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 2010, 24(3):225-234.
131. Hausenloy D.J., Yellon D.M. The second window of preconditioning (SWOP) where are we now?. Cardiovasc Drugs Ther 2010, 24(3):235-254.
132. Chen C.H., Gray M.O., Mochly-Rosen D. Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: role of epsilon protein kinase C. Proc Natl Acad Sci U S A 1999, 96(22):12784-12789.
133. Inagaki K., Mochly-Rosen D. DeltaPKC-mediated activation of epsilonPKC in ethanol-induced cardiac protection from ischemia. J Mol Cell Cardiol 2005, 39(2):203-211.
134. Sato M., Fraga C., Das D.K. Induction of the expression of cardioprotective proteins after mild-to-moderate consumption of alcohol. Pathophysiology 2004, 10(2):139-145.
135. Miyamae M., Rodriguez M.M., Camacho S.A., Diamond I., Mochly-Rosen D., Figueredo V.M. Activation of epsilon protein kinase C correlates with a cardioprotective effect of regular ethanol consumption. Proc Natl Acad Sci U S A 1998, 95(14):8262-8267.
136. Zhou H.Z., Karliner J.S., Gray M.O. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol 2002, 283(1):H165-H174.
137. Pagel P.S., Krolikowski J.G., Kehl F., Mraovic B., Kersten J.R., Warltier D.C. The role of mitochondrial and sarcolemmal K(ATP) channels in canine ethanol-induced preconditioning in vivo. Anesth Analg 2002, 94(4):841-848. table of contents.
138. Pagel P.S., Toller W.G., Gross E.R., Gare M., Kersten J.R., Warltier D.C. K(ATP) channels mediate the beneficial effects of chronic ethanol ingestion. Am J Physiol Heart Circ Physiol 2000, 279(5):H2574-H2579.
139. Zhu P., Zhou H.Z., Gray M.O. Chronic ethanol-induced myocardial protection requires activation of mitochondrial K(ATP) channels. J Mol Cell Cardiol 2000, 32(11):2091-2095.
140. Miyamae M., Camacho S.A., Zhou H.Z., Diamond I., Figueredo V.M. Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats. Am J Physiol 1998, 275(1 Pt 2):H50-H56.
141. Miyamae M., Diamond I., Weiner M.W., Camacho S.A., Figueredo V.M. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A 1997, 94(7):3235-3239.
142. Miyamae M., Domae N., Zhou H.Z., Sugioka S., Diamond I., Figueredo V.M. Phospholipase C activation is required for cardioprotection by ethanol consumption. Exp Clin Cardiol 2003, 8(4):184-188.
143. Hausenloy D.J. Signalling pathways in ischaemic postconditioning. Thromb Haemost 2009, 101(4):626-634.
144. Duan J., McFadden G.E., Borgerding A.J., Norby F.L., Ren B.H., Ye G., et al. Overexpression of alcohol dehydrogenase exacerbates ethanol-induced contractile defect in cardiac myocytes. Am J Physiol Heart Circ Physiol 2002, 282(4):H1216-H1222.
145. Liang Q., Carlson E.C., Borgerding A.J., Epstein P.N. A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther 1999, 291(2):766-772.
146. Doser T.A., Turdi S., Thomas D.P., Epstein P.N., Li S.Y., Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 2009, 119(14):1941-1949.
147. Chen C.H., Budas G.R., Churchill E.N., Disatnik M.H., Hurley T.D., Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 2008, 321(5895):1493-1495. 12.
148. Budas G.R., Disatnik M.H., Chen C.H., Mochly-Rosen D. Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol 2010, 48:757-764.
149. Ma H., Guo R., Yu L., Zhang Y., Ren J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur Heart J 2011, 32(8):1025-1038.
150. Churchill E.N., Disatnik M.H., Mochly-Rosen D. Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol 2009, 46(2):278-284.
151. Bellows S.D., Hale S.L., Kloner R.A. Acute ethanol does not protect against ischemic/reperfusion injury in rabbit myocardium. J Thromb Thrombolysis 1996, 3(3):181-184.
152. Dow J.S., Hale S.L., Kloner R.A. Can moderate alcohol intake limit the size of myocardial infarction?. J Cardiovasc Pharmacol 2001, 37(6):662-667.
153. Hale S.L., Kloner R.A. Ethanol does not exert myocardial preconditioning in an intact rabbit model of ischemia/reperfusion. Heart Dis 2001, 3(5):293-296.
154. Itoya M., Morrison J.D., Downey H.F. Effect of ethanol on myocardial infarct size in a canine model of coronary artery occlusion-reperfusion. Mol Cell Biochem 1998, 186(1-2):35-41.
155. Churchill E.N., Disatnik M.H., Budas G.R., Mochly-Rosen D. Ethanol for cardiac ischemia: the role of protein kinase c. Ther Adv Cardiovasc Dis 2008, 2(6):469-483.
156. de la Torre J.C. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci 2000, 924:136-152.
157. Kalaria R.N. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev 2010, 68(Suppl. 2):S74-S87.
158. Rhodin J.A., Thomas T. A vascular connection to Alzheimer's disease. Microcirculation 2001, 8:207-220.
159. Takano T., Han X., Deane R., Zlokovic B., Nedergaard M. Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci 2007, 1097:40-50.
160. Belmadani A., Kumar S., Schipma M., Collins M.A., Neafsey E.J. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 2004, 15:2093-2096.
161. Belmadani A., Neafsey E.J., Collins M.A. Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: Curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations. J Neurovirol 2003, 9:45-54.
162. Belmadani A., Zou J.Y., Schipma M.J., Neafsey E.J., Collins M.A. Ethanol pre-exposure suppresses HIV-1 glycoprotein 120-induced neuronal degeneration by abrogating endogenous glutamate/Ca2+-mediated neurotoxicity. Neuroscience 2001, 104:769-781.
163. Wang Q., Kalogeris T.J., Wang M., Jones A.W., Korthuis R.J. Antecedent ethanol attenuates cerebral ischemia/reperfusion-induced leukocyte-endothelial adhesive interactions and delayed neuronal death: role of large conductance, Ca2+-activated K+ channels. Microcirculation 2010, 17:427-438.
164. Wang Q., Sun A.Y., Simonyi A., Kalogeris T.J., Miller D.K., Sun G.Y., et al. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS. Free Radic Biol Med 2007, 43:1048-1060.
165. Wang Q., Tompkins K.D., Simonyi A., Korthuis R.J., Sun A.Y., Sun G.Y. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 2006, 1090:182-189.
166. Qi S.H., Liu Y., Hao L.Y., Guan Q.H., Gu Y.H., Zhang J., et al. Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release. Neuroscience 2010, 167:1125-1137.
167. Qi S.H., Liu Y., Wang W.W., Wang M., Zhang G.Y. Neuroprotection of ethanol against cerebral ischemia/reperfusion induced brain injury through GABA receptor activation. Brain Res 2009, 1276:151-158.
168. Collins M.A., Neafsey E.J., Wang K., Achille N.J., Mitchell R.M., Sivaswamy S. Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol Neurobiol 2010, 41:420-425.
169. Mitchell R.M., Neafsey E.J., Collins M.A. Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro. J Neurochem 2009, 111:580-588.
170. Sivaswamy S., Neafsey E.J., Collins M.A. Neuroprotective preconditioning of rat brain cultures with ethanol: potential transduction by PKC isoforms and focal adhesion kinase upstream of increases in effector heat shock proteins. Eur J Neurosci 2010, 32:1800-1812.
171. Chaudhury T.K., Robert A. Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate. Dig Dis Sci 1980, 25:830-836.
172. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979, 77:761-767.
173. Robert A., Nezamis J.E., Lancaster C., Davis J.P., Field S.O., Hanchar A.J. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 1983, 245:G113-G121.
174. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 1979, 77:433-443.
175. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 1983, 245:G601-G623.
176. Ko J.K., Cho C.H. Adaptive cytoprotection and the brain-gut axis. Digestion 2011, 83(Suppl. 1):19-24.
177. Ko J.K., Cho C.H. Co-regulation of mucosal nitric oxide and prostaglandin in gastric adaptive cytoprotection. Inflamm Res 1999, 48:471-478.
178. Ko J.K., Cho C.H. Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs. Dig Dis Sci 1998, 43:1248-1257.
179. Kokoska E.R., Smith G.S., Deshpande Y., Rieckenberg C.L., Miller T.A. Adaptive cytoprotection induced by ethanol in human intestinal cells: role of prostaglandins and calcium homeostasis. Ann Surg 1998, 228:123-130.
180. Takeuchi K., Araki H., Umeda M., Komoike Y., Suzuki K. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice. J Pharmacol Exp Ther 2001, 297:1160-1165.
181. Yamamoto H., Tanaka A., Kunikata T., Hirata T., Kato S., Takeuchi K. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs. J Physiol Paris 1999, 93:405-412.
182. Dinda P.K., Wasan S., Beck I.T., Kossev P. Adaptive cytoprotection against ethanol-induced small intestinal mucosal injury. Can J Physiol Pharmacol 1996, 74:598-602.
183. Gute D.C., Korthuis R.J. Inflammation in ischemia/reperfusion-induced skeletal muscle injury: role of neutrophil adhesion and ischemic preconditioning. Cell Biochem 1998, 179:169-187.
184. Gute D.C., Korthuis R.J. Role of leukocyte adherence in reperfusion-induced mircovascular dysfunction and tissue injury. Physiology and pathophysiology of leukocyte adhesion 1995, 19:359-380. Oxford Univ Press. D.N. Granger, G.W. Schmid-Schobein (Eds.).
185. Korthuis R.J., Granger D.N. Mechanisms of ischemia/reperfusion. Annu Rev Physiol 1995, 57:311-332.
186. Panes J., Granger D.N. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998, 114:1066-1090.
187. Dayton C., Yamaguchi T., Kamada K., Carter P., Korthuis R.J. Antecedent ethanol ingestion prevents postischemic leukocyte adhesion and P-selectin expression by a protein kinase C-dependent mechanism. Dig Dis Sci 2005, 50:684-690.
188. Dayton C., Yamaguchi T., Kamada K., Carter P., Korthuis R.J. Antecedent ethanol ingestion prevents postischemic P-selectin expression in murine small intestine. Microcirculation 2004, 11:709-718.
189. Gaskin F.S., Kamada K., Yusof M., Korthuis R.J. 5'-AMP-activated protein kinase activation prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2007, 292:H326-H332.
190. Gaskin F.S., Kamada K., Yusof M., Durante W., Gross G., Korthuis R.J. AICAR preconditioning prevents postischemic leukocyte rolling and adhesion: role of K(ATP) channels and heme oxygenase. Microcirculation 2009, 16:167-176.
191. Gaskin F.S., Kamada K., Zuidema M.Y., Jones A.W., Rubin L.J., Korthuis R.J. Isoform-selective 5'-AMP-activated protein kinase-dependent preconditioning mechanisms to prevent postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2011, 300:H1352-H1360.
192. Goral J., Karavitis J., Kovacs E.J. Exposure-dependent effects of ethanol on the innate immune system. Alcohol 2008, 42:237-247.
193. Imhof A., Blagieva R., Marx N., Koenig W. Drinking modulates monocyte migration in healthy subjects: a randomised intervention study of water, ethanol, red wine and beer with or without alcohol. Diab Vasc Dis Res 2008, 5:48-53.
194. Kamada K., Dayton C.B., Yamaguchi T., Korthuis R.J. Antecedent ethanol ingestion prevents postischemic microvascular dysfunction. Pathophysiology 2004, 10:131-137.
195. Kamada K., Gaskin F.S., Yamaguchi T., Carter P., Yoshikawa T., Yusof M., et al. Role of calcitonin gene-related peptide in the postischemic anti-inflammatory effects of antecedent ethanol ingestion. Am J Physiol Heart Circ Physiol 2006, 290:H531-H537.
196. Sacanella E., Estruch R. The effect of alcohol consumption on endothelial adhesion molecule expression. Addict Biol 2003, 8:371-378.
197. Sacanella E., Vazquez-Agell M., Mena M.P., Antunez E., Fernandez-Sola J., Nicolas J.M., et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: a randomized trial. Am J Clin Nutr 2007, 86:1463-1469.
198. Vrsalovic M., Vrsalovic M.M., Presecki A.V., Lukac J. Modulating role of alcohol and acetaldehyde on neutrophil and monocyte functions in vitro. J Cardiovasc Pharmacol 2007, 50:462-465.
199. Yamaguchi T., Dayton C., Shigematsu T., Carter P., Yoshikawa T., Gute D.C., et al. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am J Physiol Heart Circ Physiol 2002, 283:H1019-H1030.
200. Yamaguchi T., Dayton C.B., Ross C.R., Yoshikawa T., Gute D.C., Korthuis R.J. Late preconditioning by ethanol is initiated via an oxidant-dependent signaling pathway. Free Radic Biol Med 2003, 34:365-376.
201. Yamaguchi T., Kamada K., Dayton C., Gaskin F.S., Yusof M., Yoshikawa T., et al. Role of eNOS-derived NO in the postischemic anti-inflammatory effects of antecedent ethanol ingestion in murine small intestine. Am J Physiol Heart Circ Physiol 2007, 292:H1435-H1442.
202. Yusof M., Kamada K., Kalogeris T., Gaskin F.S., Korthuis R.J. Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am J Physiol Heart Circ Physiol 2009, 296:H868-H876.
203. Zuidema M.Y., Yang Y., Wang M., Kalogeris T., Liu Y., Meininger C.J., et al. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels. Am J Physiol Heart Circ Physiol 2010, 299:H1554-H1567.
204. Zuidema M.Y., Peyton K.J., Fay W.P., Durante W., Korthuis R.J. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol 2011, 301:H888-H894.
205. Chuang H.H., Lin S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc Natl Acad Sci U S A 2009, 106:20097-20102.
206. Zuidema M.Y., Peyton K.J., Fay W.P., Durante W., Korthuis R.J. Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol 2011.
207. Geppetti P., Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004, 141(8):1313-1320.
208. Alawi K., Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2010, 125:181-195.
209. Amadesi S., Cottrell G.S., Divino L., Chapman K., Grady E.F., Bautista F., et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J Physiol 2006, 575:555-571.
210. Liu X.M., Peyton K.J., Shebib A.R., Wang H., Korthuis R.J., Durante W. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 2011, 300:H84-H93.
211. Wandler A., Bruun J.M., Nielsen M.P., Richelsen B. Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol Cell Endocrinol 2008, 296:26-31.
212. Jones A.W., Durante W., Korthuis R.J. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. J Pharmacol Exp Ther 2010, 335:85-91.
213. Vazquez-Prieto M.A., Renna N.F., Diez E.R., Cacciamani V., Lembo C., Miatello R.M. Effect of red wine on adipocytokine expression and vascular alterations in fructose-fed rats. Am J Hypertens 2011, 24:234-240.
214. Huang P.H., Tsai H.Y., Wang C.H., Chen Y.H., Chen J.S., Lin F.Y., et al. Moderate intake of red wine improves ischemia-induced neovascularization in diabetic mice-roles of endothelial progenitor cells and nitric oxide. Atherosclerosis 2010, 212:426-435.